• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Characteristics of the interaction of anthrapyrazole anticancer agents with deoxyribonucleic acids: structural requirements for DNA binding, intercalation, and photosensitization.

作者信息

Hartley J A, Reszka K, Zuo E T, Wilson W D, Morgan A R, Lown J W

机构信息

Department of Chemistry, University of Alberta, Edmonton, Canada.

出版信息

Mol Pharmacol. 1988 Mar;33(3):265-71.

PMID:3352592
Abstract

The binding constants for interaction of several novel anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles) with DNA have been determined by an ethidium displacement method. The apparent binding constants range from less than 2 X 10(6) to 2.7 X 10(8) M-1. The binding is influenced not only by the nature of the side chains but also by the number and position of hydroxyl groups on the chromophore. Unwinding angles, determined by a topoisomerase I assay, ranged from 0 degrees to 29.2 degrees. The deshydroxy compound 1 gave the highest unwinding angle, and both substitution of hydroxyl groups in the chromophore and alterations in the side chains decrease the unwinding angle, consistent with a decreased or partial intercalation. Representative anthrapyrazoles cause an increase in sonicated DNA viscosity as expected for intercalators. Spectrophotometric examination of the binding of compound 1 to DNAs of different base composition show that the apparent binding to GC is approximately 3 times that of AT, a result which was paralleled by thermal denaturation studies. Certain of the anthrapyrazoles exhibit marked visible light photosensitization and induce DNA single-strand breakage upon illumination in the presence of NADH. The essential structural requirement for photosensitizing properties with these agents was the absence of hydroxyl groups in the chromophore. By employing 32P-labeled DNA of known sequence, it was possible to examine the anthrapyrazole 1-photosensitized cleavage of DNA at the individual base level employing denaturing polyacrylamide sequencing gels. Smooth sequence neutral photosensitized cleavage of DNA is observed analogous to hydroxyl radical "footprinting."

摘要

相似文献

1
Characteristics of the interaction of anthrapyrazole anticancer agents with deoxyribonucleic acids: structural requirements for DNA binding, intercalation, and photosensitization.
Mol Pharmacol. 1988 Mar;33(3):265-71.
2
Interaction of the antitumour alkaloid coralyne with duplex deoxyribonucleic acid structures: spectroscopic and viscometric studies.抗肿瘤生物碱珊瑚碱与双链脱氧核糖核酸结构的相互作用:光谱学和粘度测定研究。
Indian J Biochem Biophys. 1998 Dec;35(6):321-32.
3
A theoretical study of the intercalative binding of the anti-tumour drug anthrapyrazole to double-stranded oligonucleotides.抗肿瘤药物蒽吡唑与双链寡核苷酸嵌入结合的理论研究
Anticancer Drug Des. 1987 Aug;2(1):79-84.
4
Interaction of bisantrene anti-cancer agents with DNA: footprinting, structural requirements for DNA unwinding, kinetics and mechanism of binding and correlation of structural and kinetic parameters with anti-cancer activity.
Anticancer Drug Des. 1989 Mar;3(4):271-82.
5
Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.溴化乙锭与DNA的共价连接导致拓扑异构酶II介导的DNA切割增强。
Biochemistry. 1997 Dec 16;36(50):15884-91. doi: 10.1021/bi971858c.
6
Biochemical pharmacology and DNA-drug interactions by Cl-958, a new antitumor intercalator derived from a series of substituted 2H-[1]benzothiopyrano[4,3,2-cd]indazoles.由一系列取代的2H-[1]苯并硫代吡喃并[4,3,2-cd]吲唑衍生而来的新型抗肿瘤嵌入剂Cl-958的生化药理学及DNA-药物相互作用
Mol Pharmacol. 1988 Jan;33(1):84-92.
7
A structure-based 3D-QSAR study of anthrapyrazole analogues of the anticancer agents losoxantrone and piroxantrone.基于结构的抗癌药物洛索蒽醌和吡柔比星的蒽吡唑类似物的3D-QSAR研究
J Chem Inf Model. 2006 Jul-Aug;46(4):1827-35. doi: 10.1021/ci060056y.
8
Molecular determinants for DNA minor groove recognition: design of a bis-guanidinium derivative of ethidium that is highly selective for AT-rich DNA sequences.DNA小沟识别的分子决定因素:一种对富含AT的DNA序列具有高度选择性的乙锭双胍衍生物的设计。
Biochemistry. 2005 Feb 15;44(6):1941-52. doi: 10.1021/bi047983n.
9
Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity.肽基蒽醌类作为潜在的抗肿瘤药物:合成、DNA结合、氧化还原循环及生物活性。
J Med Chem. 1996 Aug 2;39(16):3114-22. doi: 10.1021/jm950924a.
10
Structures, spectra, and DNA-binding properties of mixed ligand copper(II) complexes of iminodiacetic acid: the novel role of diimine co-ligands on DNA conformation and hydrolytic and oxidative double strand DNA cleavage.亚氨基二乙酸混合配体铜(II)配合物的结构、光谱及DNA结合特性:二亚胺共配体在DNA构象以及水解和氧化双链DNA切割中的新作用
J Inorg Biochem. 2006 Mar;100(3):316-30. doi: 10.1016/j.jinorgbio.2005.11.018. Epub 2006 Jan 9.

引用本文的文献

1
An Insight into the Structure-activity Relationship of Benzimidazole and Pyrazole Derivatives as Anticancer Agents.苯并咪唑和吡唑衍生物作为抗癌剂的构效关系洞察
Curr Top Med Chem. 2025;25(4):350-377. doi: 10.2174/0115680266343336241021080438.
2
Application of Multivariate Adaptive Regression Splines (MARSplines) for Predicting Antitumor Activity of Anthrapyrazole Derivatives.多元自适应回归样条(MARSplines)在预测蒽吡唑衍生物抗肿瘤活性中的应用。
Int J Mol Sci. 2022 May 4;23(9):5132. doi: 10.3390/ijms23095132.
3
Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers.
超越 DNA 结合:综述吖啶酮在寄生虫感染、炎症和癌症中的治疗活性的潜在作用机制。
Cell Commun Signal. 2011 May 15;9:13. doi: 10.1186/1478-811X-9-13.
4
The structure-based design, synthesis and biological evaluation of DNA-binding bisintercalating bisanthrapyrazole anticancer compounds.基于结构的DNA结合双插入双蒽并吡唑抗癌化合物的设计、合成及生物学评价
Bioorg Med Chem. 2008 Apr 1;16(7):3959-68. doi: 10.1016/j.bmc.2008.01.033. Epub 2008 Jan 26.
5
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase.SP600125,一种Jun氨基末端激酶的蒽吡唑啉酮抑制剂。
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13681-6. doi: 10.1073/pnas.251194298.
6
Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell line.
Cancer Chemother Pharmacol. 1990;26(4):250-6. doi: 10.1007/BF02897225.
7
Cell-killing activity and kinetic analysis of a novel antitumor compound NC-190, a benzo[a]phenazine derivative.新型抗肿瘤化合物NC-190(一种苯并[a]吩嗪衍生物)的细胞杀伤活性及动力学分析
Jpn J Cancer Res. 1992 Apr;83(4):402-9. doi: 10.1111/j.1349-7006.1992.tb00122.x.
8
Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, CI941 and ametantrone in MCF-7 cells: comparison with doxorubicin.米托蒽醌、CI941和氨茴环素对MCF-7细胞的细胞毒性中活性氧未参与:与阿霉素的比较。
Cancer Chemother Pharmacol. 1992;30(6):451-8. doi: 10.1007/BF00685596.